Conditions: Hypogonadism Erectile Dysfunction
Keywords: hormone replacement therapy radical prostatectomy erectile dysfunctions scheduled for removal of prostate gland
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 3
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the effectiveness of testosterone replacement therapy (TRT) in men following surgery to remove the prostate in improving erectile function. Subjects will be randomized (like flipping a coin) to one of two groups. One group will receive Testim® (testosterone gel) 5 g per day plus Viagra 25 mg every night and the other will receive Placebo-Testim® 5 g per day plus Viagra 25 mg every night.

Subjects will begin drug treatment 3 months after the initial screening visit and will take study drug for 3 months only. Participation will end at the end of the 6-month visit.

Detailed description:
There was only one patient who began treatment with the study drug. After blind was broken, it was noted that he received placebo Testim and Viagra.

Arms:
arm 1: Testim® gel (50 mg of testosterone) once daily + Viagra® 25 mg tablet every night arm 2: Placebo Testim® gel once daily + Viagra® 25 mg tablet every night

Interventions: intervention 1: Testim® intervention 2: Placebo Testim® intervention 3: Viagra®
Intervention descriptions: intervention 1: Testim® 5 g of gel (one tube) containing 50 mg of testosterone once daily. This was the dose given to the patient which he started. intervention 2: Placebo Testim® 5 g of gel (one tube) intervention 3: Viagra 25mg was the dose given to the patient which he started.

Protocol document: